相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Morphological changes in skin of different phototypes under the action of topical corticosteroid therapy and tacrolimus
I. L. Shlivko et al.
SKIN RESEARCH AND TECHNOLOGY (2014)
Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis
J. M. Jensen et al.
ALLERGY (2012)
The effect of pimecrolimus on expression of genes associated with skin barrier dysfunction in atopic dermatitis skin lesions
Alicja Grzanka et al.
EXPERIMENTAL DERMATOLOGY (2012)
Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity
S. Kezic et al.
ALLERGY (2011)
Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials
J. Schmitt et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
The effect of aqueous cream BP on the skin barrier in volunteers with a previous history of atopic dermatitis
S. G. Danby et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
A systematic review of tacrolimus ointment compared with corticosteroids in the treatment of atopic dermatitis
A. Svensson et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Evaluation of the atrophogenic potential of hydrocortisone 1% cream and pimecrolimus 1% cream in uninvolved forehead skin of patients with atopic dermatitis using optical coherence tomography
Roland Aschoff et al.
EXPERIMENTAL DERMATOLOGY (2011)
Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age
C. Flohr et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Kallikrein Expression and Cathelicidin Processing Are Independently Controlled in Keratinocytes by Calcium, Vitamin D3, and Retinoic Acid
Shin Morizane et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis
Marianne Demerjian et al.
EXPERIMENTAL DERMATOLOGY (2009)
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis (Reprinted from J Allergy Clin Immunol vol 123, pg 1124-33, 2009)
Jens-Michael Jensen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome
Anais Briot et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Epidermal Barrier Dysfunction in Atopic Dermatitis
Michael J. Cork et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Clinical Severity Correlates with Impaired Barrier in Filaggrin-Related Eczema
Ikue Nemoto-Hasebe et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity
Jayanta Gupta et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Filaggrin in atopic dermatitis
Grainne M. O'Regan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Efficient and simple quantification of stratum corneum proteins on tape strippings by infrared densitometry
R. Voegeli et al.
SKIN RESEARCH AND TECHNOLOGY (2007)
Cytokine modulation of atopic dermatitis filaggrin skin expression
Michael D. Howell et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients
Nahoko Komatsu et al.
EXPERIMENTAL DERMATOLOGY (2007)
Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial
M. Cossmann et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis
CNA Palmer et al.
NATURE GENETICS (2006)
Adverse effects of topical glucocorticosteroids
UR Hengge et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity
JP Hachem et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Mechanisms of action of topical therapies and the rationale for combination therapy
DA Norris
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Stratum corneum pH in atopic dermatitis
F Rippke et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2004)
Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: Inhibition of epidermal lipid synthesis accounts for functional abnormalities
JS Kato et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis
S Reitamo et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
分享论文
